The GPI-Ib/IIIa antagonist eptifibatide markedly potentiates platelet-leukocyte interaction and tissue factor expression following platelet activation in whole blood in vitro - Scholz, T; Zhao, L; Temmler, U (Platelets, 2002)
et al.